HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structural model of MD-2 and functional role of its basic amino acid clusters involved in cellular lipopolysaccharide recognition.

Abstract
The receptor complex resulting from association of MD-2 and the ectodomain of Toll-like receptor 4 (TLR4) mediates lipopolysaccharide (LPS) signal transduction across the cell membrane. We prepared a tertiary structure model of MD-2, based on the known structures of homologous lipid-binding proteins. Analysis of circular dichroic spectra of purified bacterially expressed MD-2 indicates high content of beta-type secondary structure, in agreement with the structural model. Bacterially expressed MD-2 was able to confer LPS responsiveness to cells expressing TLR4 despite lacking glycosylation. We identified several clusters of basic residues on the surface of MD-2. Mutation of each of two clusters encompassing the residues Lys(89)-Arg(90)-Lys(91) and Lys(125)-Lys(125) significantly decreased the signal transduction of the respective MD-2 mutants either upon co-expression with TLR4 or upon addition as soluble protein into the supernatant of cells overexpressing TLR4. These basic clusters lie at the edge of the beta-sheet sandwich, which in cholesterol-binding protein connected to Niemann-Pick disease C2 (NPC2), dust mite allergen Der p2, and ganglioside GM2-activator protein form a hydrophobic pocket. In contrast, mutation of another basic cluster composed of Arg(69)-Lys(72), which according to the model lies further apart from the hydrophobic pocket only weakly decreased MD-2 activity. Furthermore, addition of the peptide, comprising the surface loop between Cys(95) and Cys(105), predicted by model, particularly in oxidized form, decreased LPS-induced production of tumor necrosis factor alpha and interleukin-8 upon application to monocytic cells and fibroblasts, respectively, supporting its involvement in LPS signaling. Our structural model of MD-2 is corroborated by biochemical analysis and contributes to the unraveling of molecular interactions in LPS recognition.
AuthorsAnton Gruber, Mateja Mancek, Hermann Wagner, Carsten J Kirschning, Roman Jerala
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 279 Issue 27 Pg. 28475-82 (Jul 02 2004) ISSN: 0021-9258 [Print] United States
PMID15111623 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amino Acids
  • Antigens, Surface
  • Carrier Proteins
  • Glycoproteins
  • Interleukin-8
  • LY96 protein, human
  • Lipopolysaccharides
  • Lymphocyte Antigen 96
  • Membrane Glycoproteins
  • NPC2 protein, human
  • Peptides
  • Receptors, Cell Surface
  • Recombinant Proteins
  • TLR4 protein, human
  • Toll-Like Receptor 4
  • Toll-Like Receptors
  • Tumor Necrosis Factor-alpha
  • Vesicular Transport Proteins
  • Pancreatic Elastase
  • cholesterol-binding protein
Topics
  • Amino Acid Motifs
  • Amino Acid Sequence
  • Amino Acids (chemistry)
  • Animals
  • Antigens, Surface (chemistry)
  • Carrier Proteins (chemistry)
  • Cell Line
  • Circular Dichroism
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • Glycoproteins (chemistry)
  • Glycosylation
  • Humans
  • Interleukin-8 (metabolism)
  • Lipopolysaccharides (chemistry)
  • Lymphocyte Antigen 96
  • Membrane Glycoproteins (chemistry, physiology)
  • Mice
  • Models, Molecular
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Mutation
  • Pancreatic Elastase
  • Peptides (chemistry)
  • Precipitin Tests
  • Protein Binding
  • Protein Conformation
  • Protein Folding
  • Protein Structure, Secondary
  • Protein Structure, Tertiary
  • Receptors, Cell Surface (chemistry, physiology)
  • Recombinant Proteins (chemistry)
  • Sequence Homology, Amino Acid
  • Signal Transduction
  • Toll-Like Receptor 4
  • Toll-Like Receptors
  • Tumor Necrosis Factor-alpha (metabolism)
  • Vesicular Transport Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: